CTABF - Canntab inks contract to create Indigenous Opiate and Illicit Drug Crisis plan

Canntab Therapeutics (OTCQB:CTABF) signed an agreement with First Nations Growers GP to create an Indigenous Opiate and Illicit Drug Crisis Plan. The plan will make Canntab's full suite of oral tablet products, which include a range of tetrahydrocannabinol  (THC) and cannabidiol (CBD) strengths, available to First Nations, Inuit and Indigenous communities and their members across Canada. The plan includes Canntab providing direct online access through a First Nations specific web portal designed to service Indigenous communities, both on and off First Nations territories. The agreement is for an initial one-year term, which is renewable, and provides for a cash fee of $30K for start-up costs and issuance of 1M warrants upon achievement of specified milestones and regulatory approval. Exercisable into one Canntab common share at $0.80/warrant for 24 months. The plan will be lead by First Nations community leader Chief Adam Pawis of the Shawanaga First Nation.

For further details see:

Canntab inks contract to create Indigenous Opiate and Illicit Drug Crisis plan